The detailed information for PTAB case with proceeding number IPR2017-01008 filed by Coherus BioSciences, Inc. against AbbVie Biotechnology Ltd. et al. on Mar 2, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.
| Document Name | Filing Date | Category | Filing Party |
|---|---|---|---|
Alert me when new update on this case | |||
Notice of Refund | Dec 1, 2017 | PAPER | BOARD |
Petitioner's Request for Refund of Post-Institution Fee | Nov 29, 2017 | PAPER | PETITIONER |
Decision Denying Institution of Inter Partes Review | Sep 7, 2017 | PAPER | BOARD |
Patent Owner's Preliminary Response | Jun 11, 2017 | PAPER | PATENT OWNER |
Wang 1999 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Jorgensen 1996 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Brazeau 1998 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Kuzu 2001 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Jorgensen 1994 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Ipp 1989 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Liu 2005 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Veys 1997 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Power of Attorney | Jun 11, 2017 | PAPER | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Jun 11, 2017 | PAPER | PATENT OWNER |
Coherus v AbbVie, IPR2016-01018, Exh 1002 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Carpenter and Manning 2002 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Chi 2003 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Salinas 2010 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Fayos 2005 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Ruiz 2006 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Chen 1994 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Raibekas 2005 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Gokarn 2008 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
USSN 14-879,847 - 4-21-17 Response to OA | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
USSN 14-643,844 - 8-24-15 Response to OA | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Yu 1998 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Lee 2013 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Daugherty 2006 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Kamerzell 2009 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Helms 1995 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Rouet 2014 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Mezzasalma 2007 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Carpenter 1997 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Humphreys 2015 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
USSN 14-879,885 - 1-17-17 Pre-Appeal Brief | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Barnett 1992 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Shire 2015 | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
ZEVALIN Label | Jun 11, 2017 | EXHIBIT | PATENT OWNER |
Order Conduct of the Proceeding | Apr 7, 2017 | PAPER | BOARD |
Notice of Accord Filing Date | Mar 24, 2017 | PAPER | BOARD |
Patent Owner's Power of Attorney | Mar 23, 2017 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Mar 23, 2017 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notices | Mar 23, 2017 | PAPER | PETITIONER |
PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 | Mar 2, 2017 | PAPER | PETITIONER |
Petitioner's Signed Power of Attorney | Mar 2, 2017 | PAPER | PETITIONER |
U.S. Patent No. 9,085,619, Fraunhofer et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2016/0319011 (Gokarn '011) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Physicians Desk Reference (2003 Humira Label) | Mar 2, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Jan. 2008) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Annex A - The Humira Story | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2003/0206898, Fischkoff et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Parslow | Mar 2, 2017 | EXHIBIT | PETITIONER |
Declaration of Klaus-Peter Radtke, Ph.D. | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. App. 60/690,582 to Gokarn (Gokarn Provisional) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Declaration of David D. Sherry, M.D. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Adalimumab Product Approval Information | Mar 2, 2017 | EXHIBIT | PETITIONER |
Gokarn et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Gelfand | Mar 2, 2017 | EXHIBIT | PETITIONER |
Fransson & Espander-Jansson | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2003/0138417, Kaisheva et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Laursen et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Nozaki & Tanford | Mar 2, 2017 | EXHIBIT | PETITIONER |
Physicians Desk Reference (Gamimune Label) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Physicians Desk Reference (56th ed. 2002) | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 13/774,735 - Part 1 of 2 | Mar 2, 2017 | EXHIBIT | PETITIONER |
Butler & Hamilton | Mar 2, 2017 | EXHIBIT | PETITIONER |
Jefferis et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
McDonnell | Mar 2, 2017 | EXHIBIT | PETITIONER |
Christensen | Mar 2, 2017 | EXHIBIT | PETITIONER |
Van Slyke | Mar 2, 2017 | EXHIBIT | PETITIONER |
Frenken et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Olthuis et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 14/506,576 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 13/774,735 - Part 2 of 2 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 12/325,049 - Part 4 of 6 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 12/325,049 - Part 1 of 6 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 12/325,049 - Part 2 of 6 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 12/325,049 - Part 3 of 6 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 12/325,049 - Part 5 of 6 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Prosecution History of App. No. 61/004,992 | Mar 2, 2017 | EXHIBIT | PETITIONER |
Schwartz | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2013/0273066 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2012/0028877 | Mar 2, 2017 | EXHIBIT | PETITIONER |
Gottlieb | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pros. History of App. No. 12/325,049 - Part 6 of 6 | Mar 2, 2017 | EXHIBIT | PETITIONER |
Stoner et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Fraunhofer Substantive Motion 3 | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2004/0033535, Boyle et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Gebhart | Mar 2, 2017 | EXHIBIT | PETITIONER |
Carnahan et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Press Release (Jan. 23, 2003) | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Pub. No. 2008/0311078 | Mar 2, 2017 | EXHIBIT | PETITIONER |
WO 2006/138181, Gokarn et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,090,382, Salfeld et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Affidavit of Marlene S. Bobka | Mar 2, 2017 | EXHIBIT | PETITIONER |
Schwartzman & Morgan | Mar 2, 2017 | EXHIBIT | PETITIONER |
Granolleras et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Annex to Note for Guidance on Development Pharmaceutics | Mar 2, 2017 | EXHIBIT | PETITIONER |
Patent Owners Preliminary Response - IPR2016-01018 | Mar 2, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Nov. 2015) | Mar 2, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Oct. 2016) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Vivaglobin Label (Jan. 2006) | Mar 2, 2017 | EXHIBIT | PETITIONER |
GAMMAGARD LIQUID Label (April 2005) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Physicians Desk Reference entry for GAMUNEX (59th ed. 2005) | Mar 2, 2017 | EXHIBIT | PETITIONER |
HepaGam Summary Basis for Approval (Jan. 2006) | Mar 2, 2017 | EXHIBIT | PETITIONER |
TYSABRI Label (Nov. 2004) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Thomson Reuters (2016) | Mar 2, 2017 | EXHIBIT | PETITIONER |
WO 1997/029131, Salfeld et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
SYNAGIS Label (July 2004) | Mar 2, 2017 | EXHIBIT | PETITIONER |
CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Affidavit of Michael Deas | Mar 2, 2017 | EXHIBIT | PETITIONER |
Flebogamma Label (Jan. 2004) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Privigen Label (Oct. 2016) | Mar 2, 2017 | EXHIBIT | PETITIONER |
AVASTIN Label (Feb. 2004) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Vectibix Label (Sept. 2006) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Akers et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Hanna, The IGIV-C Study Group | Mar 2, 2017 | EXHIBIT | PETITIONER |
Dean, Lange's Handbook of Chemistry | Mar 2, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Feb. 2008) | Mar 2, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Feb. 2007) | Mar 2, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Nov. 2006) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Meadows & Hollowell | Mar 2, 2017 | EXHIBIT | PETITIONER |
ENBREL Label (Sept. 2002) | Mar 2, 2017 | EXHIBIT | PETITIONER |
ENBREL Label (Nov. 1998) | Mar 2, 2017 | EXHIBIT | PETITIONER |
REMICADE Label (Aug. 1998) | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,696,056, Cheung et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Campath Label (Aug. 2006) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Cleland & Langer | Mar 2, 2017 | EXHIBIT | PETITIONER |
Rowe, Handbook of Pharmaceutical Excipients | Mar 2, 2017 | EXHIBIT | PETITIONER |
Note for Guidance on Development Pharmaceutics | Mar 2, 2017 | EXHIBIT | PETITIONER |
Affidavit of Christopher Butler | Mar 2, 2017 | EXHIBIT | PETITIONER |
van de Putte, et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
HUMIRA Label (Oct. 2005) | Mar 2, 2017 | EXHIBIT | PETITIONER |
Tsourounis | Mar 2, 2017 | EXHIBIT | PETITIONER |
Nash | Mar 2, 2017 | EXHIBIT | PETITIONER |
Wang | Mar 2, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,114,166 to Krause et al. | Mar 2, 2017 | EXHIBIT | PETITIONER |
Burton, D.R. et al | Mar 2, 2017 | EXHIBIT | PETITIONER |
Yim, Summary Review for Regulatory Action | Mar 2, 2017 | EXHIBIT | PETITIONER |